THROMBOGENICS
DEAD

Serial Number

79081227

Owner

ThromboGenics NV

Attorney

Lisa Greenwald-Swire

Filing Date

Jan 19, 2010

Add to watchlist:

No watchlists yet
View on USPTO

THROMBOGENICS Trademark

Serial Number: 79081227

THROMBOGENICS is a trademark filed by ThromboGenics NV on January 19, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ThromboGenics NV (13 trademarks)

Gaston Geenslaan 1
Heverlee 3001 , BE

Entity Type: 99

Trademark Details

Filing Date

January 19, 2010

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases

Chemical preparations and substances for use in the manufacture of pharmaceutical products

Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services

Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals

Filing History

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2012 REAP
DEATH OF INTERNATIONAL REGISTRATION
Nov 27, 2010 DETH
REFUSAL PROCESSED BY IB
Jun 10, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 7, 2010 RFCS
REFUSAL PROCESSED BY MPU
May 7, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 7, 2010 RFCR
NON-FINAL ACTION WRITTEN
May 6, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
May 4, 2010 MAFR
ASSIGNED TO EXAMINER
Apr 30, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 29, 2010 REPR